These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15699404)

  • 21. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Strauss MH; Weinstein J; Newton GE
    N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888
    [No Abstract]   [Full Text] [Related]  

  • 22. ACE inhibitors and stroke: new considerations.
    Sica DA
    J Clin Hypertens (Greenwich); 2002; 4(2):126-9, 133. PubMed ID: 11927795
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients.
    Okaishi K; Morimoto S; Fukuo K; Niinobu T; Hata S; Onishi T; Ogihara T
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):778-83. PubMed ID: 10480470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ASCOT trial: a closer look.
    Kaplan NM
    J Hypertens; 2006 Feb; 24(2):211-4. PubMed ID: 16508561
    [No Abstract]   [Full Text] [Related]  

  • 28. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of ASCOT on hypertension treatment and guidelines in older adults.
    Sheridan R; Baldwin N
    Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hypertension.
    Cuddy ML
    J Pract Nurs; 2006; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract]   [Full Text] [Related]  

  • 33. Patient satisfaction with antihypertensive therapy.
    Chen K; Chiou CF; Plauschinat CA; Frech F; Harper A; Dubois R
    J Hum Hypertens; 2005 Oct; 19(10):793-9. PubMed ID: 15951740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
    Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimal treatment of hypertension with diastolic heart failure.
    Susic D; Frohlich ED
    Heart Fail Clin; 2008 Jan; 4(1):117-24. PubMed ID: 18313629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.